LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 42.67 | 771.67 | 2969 | 5155 | 0.5759 | 0.6352 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 42.67 | 771.67 | 3348 | 5155 | 0.6494 | 0.7084 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 44.89 | 771.67 | 3182 | 5541 | 0.5742 | 0.6456 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 44.89 | 771.67 | 3531 | 5541 | 0.6372 | 0.7069 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 47.11 | 771.67 | 3357 | 5941 | 0.5650 | 0.6475 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 47.11 | 771.67 | 3838 | 5941 | 0.6460 | 0.7242 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 49.33 | 771.67 | 3616 | 6392 | 0.5657 | 0.6592 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 49.33 | 771.67 | 3904 | 6392 | 0.6107 | 0.7015 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 51.55 | 771.67 | 3835 | 6829 | 0.5615 | 0.6648 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 51.55 | 771.67 | 4225 | 6829 | 0.6186 | 0.7168 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 53.77 | 771.67 | 4069 | 7256 | 0.5608 | 0.6724 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 53.77 | 771.67 | 4388 | 7256 | 0.6047 | 0.7118 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 55.99 | 771.67 | 4287 | 7690 | 0.5575 | 0.6770 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 55.99 | 771.67 | 4662 | 7690 | 0.6062 | 0.7199 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 58.21 | 771.67 | 4468 | 8085 | 0.5526 | 0.6789 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 58.21 | 771.67 | 4934 | 8085 | 0.6102 | 0.7288 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 60.44 | 771.67 | 4676 | 8530 | 0.5481 | 0.6816 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 60.44 | 771.67 | 5218 | 8530 | 0.6117 | 0.7356 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 62.66 | 771.67 | 4883 | 8978 | 0.5439 | 0.6839 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 62.66 | 771.67 | 5413 | 8978 | 0.6029 | 0.7336 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 64.88 | 771.67 | 5104 | 9447 | 0.5403 | 0.6867 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 64.88 | 771.67 | 5644 | 9447 | 0.5974 | 0.7343 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 67.10 | 771.67 | 5297 | 9800 | 0.5405 | 0.6911 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 67.10 | 771.67 | 5787 | 9800 | 0.5905 | 0.7324 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 69.32 | 771.67 | 5515 | 10212 | 0.5400 | 0.6952 | MN20160304_L01 | D10 |